Product Program year 2024 Source: CMS Open Payments

(5153) Azurion 5 M20 GC

Device Medical Device

Open in the dashboard

General payments

$3,718

53 payments

Research payments

$0

0 payments

Through program year 2024, $3,718 in general payments and $0 in research payments were reported against (5153) Azurion 5 M20 GC (Medical Device).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $2,310 25
2023 General $1,294 27
2022 General $115 1

Breakdown

Who paid General payments · program years 2022–2024
  1. Philips Electronics North America Corporation $3,718 53 payments
Top recipients General payments · program year 2024
  1. Ahmad Aslam Cardiovascular Disease · Tomball, TX $282 12% · 3 payments
  2. Anderson Mehrle Cardiovascular Disease · Bartlesville, OK $156 7% · 2 payments
  3. Matthew Bunte Interventional Cardiology · Kansas City, MO $148 6% · 1 payment
  4. Rahul Bose Interventional Cardiology · New Braunfels, TX $146 6% · 1 payment
  5. Jamison Wyatt Interventional Cardiology · New Braunfels, TX $146 6% · 1 payment

The top 5 of 21 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $931 40% · 7 practitioners
  2. Cardiovascular Disease Internal Medicine $551 24% · 3 practitioners
  3. Vascular & Interventional Radiology Radiology $218 9% · 3 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $146 6% · 1 practitioner
  5. Internal Medicine $114 5% · 1 practitioner

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $1,242 54% · 10 recipients
  2. Oklahoma $271 12% · 2 recipients
  3. Ohio $193 8% · 3 recipients
  4. Missouri $148 6% · 1 recipient
  5. Arkansas $131 6% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

53 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record